Home Newsfeeds Gold Royalty Q3 Sales $1.90M

Gold Royalty Q3 Sales $1.90M

Gold Royalty (AMEX:GROY) reported $1.90 million in sales this quarter.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Gold Royalty (AMEX:GROY) reported $1.90 million in sales this quarter.

Binance Listing Propels ORDI Token To Market Spotlight With 50% Value Surge

By Murtuza Merchant

November 7, 10:26 AM

Cryptocurrency token ORDI, connected to the Bitcoin (CRYPTO: BTC) Ordinals framework, has seen a remarkable 50% leap in value over the last day.

$BNB

Celldex Therapeutics Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

By Benzinga Newsdesk

November 7, 5:59 PM

Celldex Therapeutics, Inc. ("Celldex" or the "Company") (NASDAQ:CLDX) today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public

CLDX

BMO Capital Downgrades Graphite Bio to Market Perform, Lowers Price Target to $7

By Benzinga Newsdesk

January 6, 6:04 AM

BMO Capital analyst Kostas Biliouris downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform and lowers the price target from $14 to $7.

GRPH

PMV Pharmaceuticals To Present Updated Phase 1 Data On PC14586 At The 2023 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics And Host A KOL Webinar

By Benzinga Newsdesk

October 11, 12:05 PM

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that it will present updated

PMVP

Gold Royalty Q3 Sales $1.90M

Related Posts

Binance Listing Propels ORDI Token To Market Spotlight With 50% Value Surge

Celldex Therapeutics Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

BMO Capital Downgrades Graphite Bio to Market Perform, Lowers Price Target to $7

PMV Pharmaceuticals To Present Updated Phase 1 Data On PC14586 At The 2023 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics And Host A KOL Webinar